PropThink: Data Delay Offers a Second Chance at Short-Term Gains from CPRX

[ACN Newswire] – By Jake KingWednesday morning, Catalyst Pharmaceutical Partners (NASDAQ:CPRX) announced that its previous guidance for top-line trial data at the end of September would be delayed until November. Shares … more

View todays social media effects on CPRX

View the latest stocks trending across Twitter. Click to view dashboard